PNPLA3 and fatty liver disease: In this context, we ruled-out that components of the metabolic syndrome, hepatic steatosis, alcohol consumption, and statin—as well as NSBB use—had a major impact on our findings by demonstrating that all of these factors were well balanced between patients with or without the PNPLA3 rs738409 minor allele.